EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The curious case of type I interferon signaling in cancer

Abu Sufiyan Chhipa, Valentina Boscaro, Margherita Gallicchio, Snehal Patel

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-11 · 1879 (6) · 189204

DOI: 10.1016/j.bbcan.2024.189204 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-11. Verfasst von Abu Sufiyan Chhipa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Pharmacy, Nirma University, 382481 Ahmedabad, India; Department of Drug Science and Technology, University o…. Hauptthemen laut MEDLINE: Signal Transduction, Neoplasms, Interferon Type I, Tumor Microenvironment. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 151 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytokines are the crucial signaling proteins that mediate the crosstalks between the cells of tumor microenvironment (TME). Interferon-1 (IFN-1) are the important cytokines that are widely known for their tumor suppressive roles comprising of cancer cell intrinsic and extrinsic mechanisms. Despite having known antitumor effects, IFN-1 are also reported to have tumor promoting functions under varying circumstances. This dichotomy in the functions of IFN-1 is largely attributed to the acute and chronic activation of IFN-1 signaling in TME. The chronic activation of IFN-1 signaling in tumor cells results in altered stimulation of downstream pathways that result in the expression of tumor promoting proteins, while the acute IFN-1 signaling activation maintains its tumor inhibiting functions. In the present review, we have discussed the anti- and pro-tumor actions of IFN-1 signaling under acute and chronic IFN-1 signaling activation. We have also discussed the downstream changes in signaling components that result in tumor supportive functions of a constitutive IFN-1 signaling. We have further discussed the possible strategies to overcome the detrimental effects of chronic IFN-1 pathway activation and to successfully employ IFN-1 for their beneficial anti-tumor effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionNeoplasmsInterferon Type ITumor MicroenvironmentHumansAnimals

Stichwörter der Autor:innen

CancerIFN-1ISGF3STATTMEuISGF3uSTAT

Substanzen

Interferon Type I

Autor:innen und Institutionen

  • Department of Pharmacology, Institute of Pharmacy, Nirma University, 382481 Ahmedabad, India; Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy.
  • Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy.
  • Department of Pharmacology, Institute of Pharmacy, Nirma University, 382481 Ahmedabad, India. Electronic address: snehal.patel@nirmauni.ac.in.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Chhipa, A. S., Boscaro, V., Gallicchio, M., & Patel, S. (2024). The curious case of type I interferon signaling in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(6), 189204. https://doi.org/10.1016/j.bbcan.2024.189204

Vancouver

Chhipa AS, Boscaro V, Gallicchio M, Patel S. The curious case of type I interferon signaling in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(6):189204. doi:10.1016/j.bbcan.2024.189204

BibTeX
@article{Chhipa2024,
  author = {Chhipa, Abu Sufiyan and Boscaro, Valentina and Gallicchio, Margherita and Patel, Snehal},
  title = {The curious case of type I interferon signaling in cancer},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2024},
  volume = {1879},
  number = {6},
  pages = {189204},
  doi = {10.1016/j.bbcan.2024.189204}
}
Kostenlos starten →